Sarepta Therapeutics, Inc. is a California-based biopharmaceutical company that develops treatments for rare genetic diseases, including Duchenne muscular dystrophy. Its disclosed lobbying focuses on patient access to treatments, newborn screening for rare diseases, scientific and technological issues such as gene therapies and artificial intelligence in healthcare, and tax rules affecting the sector. The company appears to lobby directly in-house.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr KIP PAYNE
The latest disclosures for this client.
SAREPTA THERAPEUTICS, INC.
Q2SAREPTA THERAPEUTICS, INC.
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
SAREPTA THERAPEUTICS, INC.
MADISON SMITH
SAREPTA THERAPEUTICS, INC.
CAROLYN HICKEY
SAREPTA THERAPEUTICS, INC.
SAREPTA THERAPEUTICS, INC.
Q4SAREPTA THERAPEUTICS, INC.
Q3SAREPTA THERAPEUTICS, INC.
Q2SAREPTA THERAPEUTICS, INC.
Q1